The Murthy Fund, established by renowned immigration attorney Sheela Murthy, remains a cornerstone in sustaining legal aid for immigrants through Harvard’s Immigration Clinical Program. This collaboration exemplifies how targeted philanthropic efforts can strengthen the immigration ecosystem, offering benefits beyond direct client representation. From our perspective, such programs indirectly support corporate immigration by expanding legal research, training, and advocacy that improve USCIS adjudication standards and access to justice.

In practice, we have seen that clients—especially Chinese corporate executives and investors—can benefit from awareness of these legal clinics’ work. For example, recent Harvard clinical projects have focused on clarifying evidentiary standards in L-1 and EB-1C adjudications, which aligns with USCIS’s 8 CFR §214.2(l) requirements. This kind of research helps practitioners anticipate USCIS’s concerns and prepare stronger petitions with well-documented organizational charts and detailed job duties, reducing RFEs and denials.

Attorney Insight
One concrete case from our firm involved a fintech client applying for an EB-1C petition. The supporting evidence referenced a Harvard clinical report analyzing USCIS’s evolving interpretation of “executive capacity” under INA §203(b)(1)(C). Leveraging these insights, we preemptively addressed potential challenges, resulting in an approval without a Request for Evidence. This illustrates how staying informed about academic and clinical legal developments can translate into tangible case advantages.

From a strategic standpoint, we suggest clients actively monitor updates from legal aid programs like the Murthy Fund-supported clinics. While these programs do not directly file petitions, their policy memos and case studies often signal USCIS’s shifting priorities. For example, recent Harvard clinic recommendations emphasize robust proof of sustained managerial roles for L-1A transfers and detailed investment tracking for EB-5 applicants. Aligning petition preparation with these recommendations can streamline processing.

Actionable steps include:

  1. 1Regularly reviewing publications and webinars produced by immigration clinical programs to anticipate USCIS’s focus areas.
  2. 2Incorporating clinical research findings into petition evidence packages, especially for complex categories like EB-1C and EB-5, where organizational and financial documentation are scrutinized under 8 CFR §§204.5(j)(5)(vi) and 204.6 respectively.

Looking ahead, the Murthy Fund’s sustained support suggests that immigration legal clinics will continue to be a valuable resource, particularly as USCIS policies evolve. We predict that these programs will increasingly influence how evidence is evaluated, especially for high-level corporate immigration cases. This trend underscores the importance of leveraging all available legal scholarship and clinical expertise to enhance petition quality.

Attorney Insight
In sum, while the Murthy Fund’s direct impact may seem peripheral to individual applicants, from a practical perspective, its support of Harvard’s Immigration Clinical Program strengthens the broader immigration legal framework. For Chinese business leaders pursuing L-1 or EB-1C petitions, or investors navigating EB-5 complexities, engaging with insights from these programs offers a competitive edge. We recommend integrating clinical legal research into your preparation process and consulting with your attorney on how to best apply these resources to your case strategy.